Is ctDNA ready to outpace imaging in monitoring early and advanced breast cancer?

Lorenzo FoffanoRiccardo VidaAlberto PiacentiniElisabetta MolteniLinda CuccinielloLucia Da RosBuriolla SilviaLorenzo CereserRossana RoncatoLorenzo GerratanaFabio Puglisi

Published in: Expert review of anticancer therapy (2024)

Numerous are the current technical, strategic, and economic challenges preventing the clinical integration of ctDNA analysis in the breast cancer monitoring. Understanding these complexities and devising targeted strategies is pivotal to effectively embedding this methodology into personalized patient care.

Keyphrases

circulating tumor
high resolution
cancer therapy
mass spectrometry
breast cancer risk
photodynamic therapy